Carcinoma NOS Completed Phase 1 Trials for Sorafenib (DB00398)

Also known as: Carcinoma / Carcinomas / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Cancer / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0044642 (Carcinoma NOS)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00941863Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)Treatment